Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Heart valve innovation at a crossroads | New data on DCD heart transplants | Private equity firm jumps into vascular health
Tuesday, July 1, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

At a crossroads: Surgical heart valve innovation slows as transcatheter treatments keep evolving

Has the success of TAVR and other interventional techniques had a negative impact on surgical valve innovation? Two surgeons shared their concerns in a new commentary. 

READ MORE >
man making a decision
Share on Twitter Share on Facebook Share on Linkedin

At a crossroads: Surgical heart valve innovation slows as transcatheter treatments keep evolving

Share on Twitter Share on Facebook Share on Linkedin
man making a decision
Has the success of TAVR and other interventional techniques had a negative impact on surgical valve innovation? Two surgeons shared their concerns in a new commentary. 
READ MORE >

Women less likely to receive DCD heart transplants

Donation after circulatory death heart transplants are gaining popularity in the United States, but men are much more likely to be selected for one. 

READ MORE >
artificial intelligence AI in healthcare
Share on Twitter Share on Facebook Share on Linkedin

Women less likely to receive DCD heart transplants

Share on Twitter Share on Facebook Share on Linkedin
artificial intelligence AI in healthcare
Donation after circulatory death heart transplants are gaining popularity in the United States, but men are much more likely to be selected for one. 
READ MORE >

Private equity firm jumps into vascular health with new investment

Vascular Technology, first founded 40 years ago, is planning on using the new funds to grow and expand its portfolio.

READ MORE >
healthcare money economics dollar stethoscope acquire merger
Share on Twitter Share on Facebook Share on Linkedin

Private equity firm jumps into vascular health with new investment

Share on Twitter Share on Facebook Share on Linkedin
healthcare money economics dollar stethoscope acquire merger
Vascular Technology, first founded 40 years ago, is planning on using the new funds to grow and expand its portfolio.
READ MORE >

Featured Articles

Female heart surgeons take home much lower salaries

Both base salaries and total compensation are consistently lower for women than men, according to new survey data. The disparities in cardiac surgery are often worse than those found in other healthcare specialties.

READ MORE >
women doctors
Share on Twitter Share on Facebook Share on Linkedin

Female heart surgeons take home much lower salaries

Share on Twitter Share on Facebook Share on Linkedin
women doctors
Both base salaries and total compensation are consistently lower for women than men, according to new survey data. The disparities in cardiac surgery are often worse than those found in other healthcare specialties.
READ MORE >

Effective, but not worth the cost: CEPD use during TAVR fails to make a significant difference

Cerebral embolic protection devices are proven to work. However, according to one cardiologist, they are still not consistently reducing stroke rates.

READ MORE >
Boston Scientific's Sentinel Cerebral Protection System during a TAVR procedure prevents emboli released from going to the brain and causing a stroke.
Share on Twitter Share on Facebook Share on Linkedin

Effective, but not worth the cost: CEPD use during TAVR fails to make a significant difference

Share on Twitter Share on Facebook Share on Linkedin
Boston Scientific's Sentinel Cerebral Protection System during a TAVR procedure prevents emboli released from going to the brain and causing a stroke.
Cerebral embolic protection devices are proven to work. However, according to one cardiologist, they are still not consistently reducing stroke rates.
READ MORE >

Polymer heart valve, the first of its kind to gain commercial approval, linked to positive 1-year data

The new-look mitral valve is built using LifePolymer, a proprietary material that does not include any animal tissue. Both the frame and its leaflets are robotically generated to match each patient’s anatomy.

READ MORE >
Tria Mitral Valve Foldax
Share on Twitter Share on Facebook Share on Linkedin

Polymer heart valve, the first of its kind to gain commercial approval, linked to positive 1-year data

Share on Twitter Share on Facebook Share on Linkedin
Tria Mitral Valve Foldax
The new-look mitral valve is built using LifePolymer, a proprietary material that does not include any animal tissue. Both the frame and its leaflets are robotically generated to match each patient’s anatomy.
READ MORE >

In Case You Missed It

Q&A: Cardiologist and EARLY TAVR co-author questions study’s execution

The EARLY TAVR clinical trial made a significant impact, paving the way for the FDA to approve multiple transcatheter heart valves for the treatment of asymptomatic patients. However, one cardiologist who participated in the trial has some serious concerns with how its findings were presented to the public. 

READ MORE >
Hemal Gada, MD, cardiologist
Share on Twitter Share on Facebook Share on Linkedin

Q&A: Cardiologist and EARLY TAVR co-author questions study’s execution

Share on Twitter Share on Facebook Share on Linkedin
Hemal Gada, MD, cardiologist
The EARLY TAVR clinical trial made a significant impact, paving the way for the FDA to approve multiple transcatheter heart valves for the treatment of asymptomatic patients. However, one cardiologist who participated in the trial has some serious concerns with how its findings were presented to the public. 
READ MORE >

‘Unqualified and fraudulent’ cardiologist linked to three patient deaths

The doctor is accused of using fake credentials for several months and performing approximately 50 procedures. This is the second time in recent months someone has been accused of impersonating a heart specialist and treating patients.

READ MORE >
doctor_patients.jpg
Share on Twitter Share on Facebook Share on Linkedin

‘Unqualified and fraudulent’ cardiologist linked to three patient deaths

Share on Twitter Share on Facebook Share on Linkedin
doctor_patients.jpg
The doctor is accused of using fake credentials for several months and performing approximately 50 procedures. This is the second time in recent months someone has been accused of impersonating a heart specialist and treating patients.
READ MORE >

Medtronic’s diabetes spin-off gets a name, kicking off ‘new and exciting chapter’

The new name will be familiar to anyone who knows the history of Medtronic's diabetes business.

READ MORE >
business launch
Share on Twitter Share on Facebook Share on Linkedin

Medtronic’s diabetes spin-off gets a name, kicking off ‘new and exciting chapter’

Share on Twitter Share on Facebook Share on Linkedin
business launch
The new name will be familiar to anyone who knows the history of Medtronic's diabetes business.
READ MORE >

In Other News

DOJ announces 324 arrests in $14.6B healthcare fraud crackdown

Of those arrested, 96 are doctors, nurses and other healthcare providers. All face charges related to telehealth prescriptions, illegal opioid distribution and fraudulent billing practices.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

DOJ announces 324 arrests in $14.6B healthcare fraud crackdown

Share on Twitter Share on Facebook Share on Linkedin
Of those arrested, 96 are doctors, nurses and other healthcare providers. All face charges related to telehealth prescriptions, illegal opioid distribution and fraudulent billing practices.
READ MORE >

AI helps spot fatty liver disease on routine radiographs

If left undiagnosed and untreated for a prolonged period, fatty liver disease can progress to more serious conditions, such as cirrhosis and liver cancer.

READ MORE >
AI spots fatty liver on chest x-rays.
Share on Twitter Share on Facebook Share on Linkedin

AI helps spot fatty liver disease on routine radiographs

Share on Twitter Share on Facebook Share on Linkedin
AI spots fatty liver on chest x-rays.
If left undiagnosed and untreated for a prolonged period, fatty liver disease can progress to more serious conditions, such as cirrhosis and liver cancer.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup